Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

drained using a chest drain, inserted under ultrasound or CT guidance. • Intra-pleural alteplase and dornase alfa may help with empyema. • Surgery: Persistent collections and increasing pleural thickness (on ultrasound) requires surgery. 50 __OOHHCCMM__1100ee..iinnddbb 119922 0022//0055//22001177 1199::0077 enicidem tsehC Table 4.9 Pleural fl uid analysis 193 Gross appearance Cause Clear, straw-coloured Transudate, exudate Turbid, yellow Empyema, parapneumonic eff usion 5 Haemorrhagic Trauma, malignancy, pulmonary infarction Cytology Neutrophils ++ Parapneumonic eff usion, PE Lymphocytes ++ Malignancy, TB, RA, SLE, sarcoidosis Mesothelial cells ++ Pulmonary infarction Abnormal mesothelial cells Mesothelioma Multinucleated giant cells RA Lupus erythematosus cells SLE Malignant cells Malignancy Clinical chemistry *Protein <25g/L Transudate >35g/L Exudate 25–35g/L If pleural fl uid protein/serum protein >0.5, eff u- sion is an exudate (85% specifi c and sensitive) Glucose <3.3mmol/L Empyema, malignancy, TB, RA, SLE pH <7.2 Empyema, malignancy, TB, RA, SLE *LDH (pleural:serum >0.6) Empyema, malignancy, TB, RA, SLE Amylase Pancreatitis, carcinoma, bacterial pneumonia, oesophageal rupture Immunology Rheumatoid factor RA Antinuclear antibody SLE Complement levels RA, SLE, malignancy, infection * Light’s criteria for defi ning an exudate: eff usion protein/serum protein >0.5; eff usion LDH/serum LDH >0.6; eff usion LDH > ⅔ upper reference range. 98% sensitive and 83% specifi c.
